- call +1-201-465-4211
- email sales@mrinsights.biz
Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease.
Scope of the Report:
The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccines; recently developed vaccines that are safer and more effective; better public awareness; technological advancements in molecular genetics domain; and the adoption of novel vaccine delivery mechanisms are primarily driving the growth of the global vaccination market. Moreover, the development of new therapeutic and prophylactic vaccines for combating HIV/AIDS, congenital abnormalities, malaria, SARS and cancer, as well as other fatal diseases is also contributing the market's growth.
The global Vaccines & Vaccination market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Vaccines & Vaccination.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Vaccines & Vaccination market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Vaccines & Vaccination market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Market Segment by Applications, can be divided into
Pediatrics disease market
Global adults disease
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Vaccines & Vaccination Market Overview
1.1 Product Overview and Scope of Vaccines & Vaccination
1.2 Classification of Vaccines & Vaccination by Types
1.2.1 Global Vaccines & Vaccination Revenue Comparison by Types (2017-2023)
1.2.2 Global Vaccines & Vaccination Revenue Market Share by Types in 2017
1.2.3 Subunit vaccines
1.2.4 Live attenuated vaccines
1.2.5 Conjugate vaccines
1.2.6 Inactivated vaccines
1.2.7 Recombinant vector vaccines
1.2.8 Toxoid vaccines
1.2.9 Synthetic vaccines
1.2.10 Dendritic cell vaccines
1.3 Global Vaccines & Vaccination Market by Application
1.3.1 Global Vaccines & Vaccination Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pediatrics disease market
1.3.3 Global adults disease
1.4 Global Vaccines & Vaccination Market by Regions
1.4.1 Global Vaccines & Vaccination Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Vaccines & Vaccination Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Vaccines & Vaccination Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Vaccines & Vaccination Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Vaccines & Vaccination Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Vaccines & Vaccination Status and Prospect (2013-2023)
1.5 Global Market Size of Vaccines & Vaccination (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Vaccines & Vaccination Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Vaccines & Vaccination Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bavarian Nordic
2.3.1 Business Overview
2.3.2 Vaccines & Vaccination Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bavarian Nordic Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Vaccines & Vaccination Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bharat Biotech
2.5.1 Business Overview
2.5.2 Vaccines & Vaccination Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bharat Biotech Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Med
2.6.1 Business Overview
2.6.2 Vaccines & Vaccination Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Med Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.7 CSL
2.7.1 Business Overview
2.7.2 Vaccines & Vaccination Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CSL Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.8 Emergent BioSolutions
2.8.1 Business Overview
2.8.2 Vaccines & Vaccination Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Emergent BioSolutions Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.9 GSK
2.9.1 Business Overview
2.9.2 Vaccines & Vaccination Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GSK Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Vaccines & Vaccination Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Vaccines & Vaccination Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck
2.12.1 Business Overview
2.12.2 Vaccines & Vaccination Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Vaccines & Vaccination Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Vaccines & Vaccination Revenue, Gross Margin and Market Share (2016-2017)
3 Global Vaccines & Vaccination Market Competition, by Players
3.1 Global Vaccines & Vaccination Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Vaccines & Vaccination Players Market Share
3.2.2 Top 10 Vaccines & Vaccination Players Market Share
3.3 Market Competition Trend
4 Global Vaccines & Vaccination Market Size by Regions
4.1 Global Vaccines & Vaccination Revenue and Market Share by Regions
4.2 North America Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
4.3 Europe Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
4.5 South America Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
5 North America Vaccines & Vaccination Revenue by Countries
5.1 North America Vaccines & Vaccination Revenue by Countries (2013-2018)
5.2 USA Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
5.3 Canada Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
5.4 Mexico Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
6 Europe Vaccines & Vaccination Revenue by Countries
6.1 Europe Vaccines & Vaccination Revenue by Countries (2013-2018)
6.2 Germany Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
6.3 UK Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
6.4 France Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
6.5 Russia Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
6.6 Italy Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Vaccines & Vaccination Revenue by Countries
7.1 Asia-Pacific Vaccines & Vaccination Revenue by Countries (2013-2018)
7.2 China Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
7.3 Japan Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
7.4 Korea Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
7.5 India Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
8 South America Vaccines & Vaccination Revenue by Countries
8.1 South America Vaccines & Vaccination Revenue by Countries (2013-2018)
8.2 Brazil Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
8.3 Argentina Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
8.4 Colombia Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Vaccines & Vaccination by Countries
9.1 Middle East and Africa Vaccines & Vaccination Revenue by Countries (2013-2018)
9.2 Saudi Arabia Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
9.3 UAE Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
9.4 Egypt Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
9.5 Nigeria Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
9.6 South Africa Vaccines & Vaccination Revenue and Growth Rate (2013-2018)
10 Global Vaccines & Vaccination Market Segment by Type
10.1 Global Vaccines & Vaccination Revenue and Market Share by Type (2013-2018)
10.2 Global Vaccines & Vaccination Market Forecast by Type (2018-2023)
10.3 Subunit vaccines Revenue Growth Rate (2013-2023)
10.4 Live attenuated vaccines Revenue Growth Rate (2013-2023)
10.5 Conjugate vaccines Revenue Growth Rate (2013-2023)
10.6 Inactivated vaccines Revenue Growth Rate (2013-2023)
10.7 Recombinant vector vaccines Revenue Growth Rate (2013-2023)
10.8 Toxoid vaccines Revenue Growth Rate (2013-2023)
10.9 Synthetic vaccines Revenue Growth Rate (2013-2023)
10.10 Dendritic cell vaccines Revenue Growth Rate (2013-2023)
11 Global Vaccines & Vaccination Market Segment by Application
11.1 Global Vaccines & Vaccination Revenue Market Share by Application (2013-2018)
11.2 Vaccines & Vaccination Market Forecast by Application (2018-2023)
11.3 Pediatrics disease market Revenue Growth (2013-2018)
11.4 Global adults disease Revenue Growth (2013-2018)
12 Global Vaccines & Vaccination Market Size Forecast (2018-2023)
12.1 Global Vaccines & Vaccination Market Size Forecast (2018-2023)
12.2 Global Vaccines & Vaccination Market Forecast by Regions (2018-2023)
12.3 North America Vaccines & Vaccination Revenue Market Forecast (2018-2023)
12.4 Europe Vaccines & Vaccination Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Vaccines & Vaccination Revenue Market Forecast (2018-2023)
12.6 South America Vaccines & Vaccination Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Vaccines & Vaccination Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Vaccines & Vaccination Picture
Table Product Specifications of Vaccines & Vaccination
Table Global Vaccines & Vaccination and Revenue (Million USD) Market Split by P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
